Snodgrass H. Ralph

Avg. Two Year Performance

No purchase track record

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	50%	36%	21%	0%	0%
Purchase Success Rate	1 of 2	1 of 2	1 of 2	0 of 2	0 of 2
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Vistagen Therapeutics, Inc.

Drugs » Biotechnology

PRES./CHIEF SCIENTIFIC OFFICER:

Holdings: 98.86K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--